RBEP (n = 40) | Placebo (n = 37) | |||||
---|---|---|---|---|---|---|
Week 0 | Week 4 | Week 8 | Week 0 | Week 4 | Week 8 | |
Natural killer cell activity (%) | 11.48 ± 7.93 | 14.44 ± 6.66 | 14.67 ± 7.62 | 9.96 ± 6.42 | 12.50 ± 6.23 | 15.25 ± 7.97 |
Interferon-γ (pg/mL) | 27.98 ± 15.10 | 28.48 ± 14.47 | 35.56 ± 17.662 | 26.19 ± 11.61 | 26.14 ± 11.55 | 27.04 ± 12.512 |
Interleukin-2 (pg/mL) | 5.66 ± 7.22 | 5.63 ± 6.42 | 4.51 ± 3.99 | 5.97 ± 11.95 | 9.04 ± 28.90 | 4.94 ± 5.73 |
Interleukin-4 (pg/mL) | 0.07 ± 0.06 | 0.08 ± 0.08 | 0.08 ± 0.09 | 0.08 ± 0.12 | 0.08 ± 0.13 | 0.08 ± 0.11 |
Interleukin-10 (pg/mL) | 2.63 ± 9.14 | 3.83 ± 13.10 | 1.53 ± 5.14 | 9.30 ± 44.63 | 9.26 ± 44.14 | 8.59 ± 43.59 |
Interleukin-12 (pg/mL) | 16.91 ± 62.78 | 20.55 ± 73.79 | 9.33 ± 24.32 | 11.12 ± 36.21 | 12.77 ± 40.62 | 10.62 ± 37.61 |
Tumor necrosis factor-α (pg/mL) | 0.66 ± 0.64 | 0.91 ± 0.88 | 0.57 ± 0.53 | 0.57 ± 0.50 | 0.77 ± 0.65 | 0.49 ± 0.37 |